Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Kinase Inhibitors | 37 | 2024 | 5695 | 2.670 |
Why?
|
Models, Molecular | 68 | 2024 | 5383 | 2.420 |
Why?
|
Crystallography, X-Ray | 44 | 2024 | 1947 | 2.250 |
Why?
|
Protein Conformation | 42 | 2021 | 3947 | 1.840 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2023 | 2054 | 1.600 |
Why?
|
Microfilament Proteins | 8 | 2017 | 1130 | 1.410 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 8 | 2014 | 182 | 1.370 |
Why?
|
ras Proteins | 4 | 2024 | 1054 | 1.350 |
Why?
|
Protein Structure, Tertiary | 35 | 2014 | 3750 | 1.320 |
Why?
|
src Homology Domains | 18 | 2016 | 361 | 1.120 |
Why?
|
Janus Kinase 2 | 6 | 2019 | 562 | 1.110 |
Why?
|
Mutation | 42 | 2024 | 30210 | 1.080 |
Why?
|
Actins | 8 | 2017 | 2061 | 1.070 |
Why?
|
Drug Resistance, Neoplasm | 18 | 2024 | 5334 | 1.060 |
Why?
|
Adenosine Triphosphate | 11 | 2024 | 2002 | 1.010 |
Why?
|
Lung Neoplasms | 27 | 2024 | 13483 | 0.990 |
Why?
|
raf Kinases | 2 | 2024 | 116 | 0.940 |
Why?
|
Amino Acid Sequence | 54 | 2017 | 13400 | 0.910 |
Why?
|
Macrocyclic Compounds | 1 | 2024 | 68 | 0.900 |
Why?
|
Binding Sites | 36 | 2024 | 6002 | 0.890 |
Why?
|
14-3-3 Proteins | 4 | 2024 | 221 | 0.880 |
Why?
|
Protein Binding | 44 | 2020 | 9302 | 0.850 |
Why?
|
Protein-Tyrosine Kinases | 17 | 2015 | 2425 | 0.820 |
Why?
|
Exons | 6 | 2024 | 2392 | 0.800 |
Why?
|
Molecular Sequence Data | 52 | 2015 | 17597 | 0.800 |
Why?
|
Protein Structure, Secondary | 15 | 2020 | 1211 | 0.770 |
Why?
|
Phosphorylation | 34 | 2022 | 8290 | 0.760 |
Why?
|
MAP Kinase Signaling System | 4 | 2023 | 1490 | 0.740 |
Why?
|
Benzeneacetamides | 2 | 2019 | 36 | 0.690 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2021 | 252 | 0.680 |
Why?
|
src-Family Kinases | 12 | 2015 | 539 | 0.680 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2015 | 1836 | 0.660 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2017 | 2898 | 0.650 |
Why?
|
Cryoelectron Microscopy | 2 | 2023 | 645 | 0.650 |
Why?
|
Signal Transduction | 35 | 2024 | 23600 | 0.640 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 14 | 2024 | 5388 | 0.620 |
Why?
|
Antineoplastic Agents | 22 | 2024 | 13635 | 0.610 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 330 | 0.580 |
Why?
|
Receptor Protein-Tyrosine Kinases | 6 | 2021 | 1621 | 0.570 |
Why?
|
Imidazoles | 2 | 2021 | 1169 | 0.570 |
Why?
|
Mutant Proteins | 3 | 2016 | 487 | 0.570 |
Why?
|
Quinazolines | 12 | 2022 | 1366 | 0.560 |
Why?
|
Intracellular Signaling Peptides and Proteins | 12 | 2022 | 2879 | 0.550 |
Why?
|
Carrier Proteins | 10 | 2014 | 4910 | 0.550 |
Why?
|
Protein Multimerization | 8 | 2019 | 959 | 0.530 |
Why?
|
Dimerization | 13 | 2013 | 881 | 0.530 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1765 | 0.510 |
Why?
|
Molecular Structure | 8 | 2024 | 1881 | 0.480 |
Why?
|
Drug Design | 5 | 2021 | 1040 | 0.480 |
Why?
|
Sequence Homology, Amino Acid | 14 | 2012 | 2743 | 0.470 |
Why?
|
TYK2 Kinase | 2 | 2014 | 38 | 0.470 |
Why?
|
Immunoglobulins | 6 | 2004 | 853 | 0.460 |
Why?
|
Allosteric Regulation | 7 | 2021 | 425 | 0.440 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 938 | 0.430 |
Why?
|
Enzyme Activation | 13 | 2021 | 3584 | 0.430 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 5 | 1999 | 147 | 0.420 |
Why?
|
Thiazoles | 3 | 2019 | 1528 | 0.420 |
Why?
|
Cell Proliferation | 11 | 2019 | 10431 | 0.410 |
Why?
|
Mutagenesis, Insertional | 4 | 2024 | 663 | 0.410 |
Why?
|
Sequence Alignment | 13 | 2016 | 2175 | 0.410 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.400 |
Why?
|
Protein Processing, Post-Translational | 4 | 2015 | 1961 | 0.380 |
Why?
|
Oogenesis | 1 | 2011 | 125 | 0.360 |
Why?
|
Structure-Activity Relationship | 10 | 2024 | 3051 | 0.360 |
Why?
|
Pyrimidines | 7 | 2024 | 3050 | 0.350 |
Why?
|
rho GTP-Binding Proteins | 3 | 2007 | 279 | 0.350 |
Why?
|
Glycoproteins | 7 | 2004 | 2197 | 0.350 |
Why?
|
Staurosporine | 3 | 2007 | 240 | 0.340 |
Why?
|
Trans-Activators | 5 | 2004 | 2849 | 0.340 |
Why?
|
Protein Tyrosine Phosphatases | 5 | 2021 | 457 | 0.340 |
Why?
|
Phosphatidylinositols | 2 | 2008 | 276 | 0.340 |
Why?
|
Molecular Dynamics Simulation | 1 | 2013 | 422 | 0.340 |
Why?
|
Interferon-alpha | 1 | 2014 | 909 | 0.330 |
Why?
|
Animals | 68 | 2025 | 168801 | 0.330 |
Why?
|
Saccharomyces cerevisiae | 4 | 2015 | 2677 | 0.330 |
Why?
|
Oncogenes | 2 | 2022 | 1231 | 0.320 |
Why?
|
rho-Associated Kinases | 1 | 2011 | 291 | 0.320 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 5 | 2003 | 93 | 0.320 |
Why?
|
Cell Line, Tumor | 25 | 2023 | 17071 | 0.320 |
Why?
|
Nuclear Proteins | 6 | 2021 | 5791 | 0.310 |
Why?
|
Proto-Oncogene Proteins | 11 | 2005 | 4520 | 0.310 |
Why?
|
Protein Isoforms | 6 | 2023 | 1715 | 0.310 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2825 | 0.300 |
Why?
|
Ubiquitination | 1 | 2013 | 1000 | 0.300 |
Why?
|
Protein Structure, Quaternary | 3 | 2004 | 423 | 0.300 |
Why?
|
Acrylamides | 3 | 2021 | 260 | 0.290 |
Why?
|
Cytoskeletal Proteins | 3 | 2005 | 1321 | 0.290 |
Why?
|
Phosphotyrosine | 6 | 2015 | 459 | 0.280 |
Why?
|
Aniline Compounds | 3 | 2022 | 1078 | 0.270 |
Why?
|
Humans | 111 | 2025 | 766019 | 0.270 |
Why?
|
Tyrosine | 7 | 2011 | 1427 | 0.270 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2009 | 429 | 0.270 |
Why?
|
Focal Adhesions | 2 | 2011 | 113 | 0.270 |
Why?
|
Fetal Proteins | 1 | 2007 | 99 | 0.270 |
Why?
|
Macromolecular Substances | 6 | 2016 | 1430 | 0.270 |
Why?
|
Drosophila Proteins | 3 | 2011 | 1703 | 0.260 |
Why?
|
Phosphoproteins | 6 | 2000 | 2445 | 0.250 |
Why?
|
Morpholines | 1 | 2008 | 584 | 0.250 |
Why?
|
Lymphoproliferative Disorders | 4 | 2003 | 526 | 0.240 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2793 | 0.240 |
Why?
|
PTEN Phosphohydrolase | 3 | 2021 | 1117 | 0.240 |
Why?
|
Genetic Variation | 1 | 2020 | 6611 | 0.240 |
Why?
|
Allosteric Site | 3 | 2024 | 106 | 0.230 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2009 | 453 | 0.230 |
Why?
|
Zinc | 3 | 2003 | 675 | 0.230 |
Why?
|
Phosphopeptides | 5 | 1999 | 240 | 0.230 |
Why?
|
Receptor, erbB-2 | 5 | 2022 | 2593 | 0.220 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2015 | 447 | 0.220 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2025 | 169 | 0.210 |
Why?
|
Prokaryotic Cells | 1 | 2003 | 53 | 0.210 |
Why?
|
Amino Acid Motifs | 7 | 2010 | 924 | 0.210 |
Why?
|
Adhesins, Bacterial | 1 | 2003 | 118 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2454 | 0.200 |
Why?
|
Transcription Factors | 8 | 2016 | 12128 | 0.200 |
Why?
|
Neoplasms | 6 | 2024 | 22336 | 0.200 |
Why?
|
HMGB Proteins | 1 | 2001 | 45 | 0.190 |
Why?
|
Protein Phosphatase 1 | 1 | 2022 | 135 | 0.190 |
Why?
|
Drug Resistance | 1 | 2008 | 1592 | 0.190 |
Why?
|
Tryptophan | 2 | 2001 | 484 | 0.190 |
Why?
|
Anthranilate Synthase | 1 | 2001 | 5 | 0.190 |
Why?
|
Enzyme Stability | 1 | 2021 | 218 | 0.180 |
Why?
|
Peptides | 7 | 2016 | 4338 | 0.180 |
Why?
|
Janus Kinase 3 | 2 | 2015 | 75 | 0.180 |
Why?
|
Mitosis | 3 | 2016 | 1175 | 0.180 |
Why?
|
Nerve Tissue Proteins | 2 | 2011 | 4399 | 0.170 |
Why?
|
Protein Kinases | 3 | 2024 | 1610 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4960 | 0.170 |
Why?
|
Substrate Specificity | 9 | 2015 | 1751 | 0.170 |
Why?
|
Mice | 32 | 2025 | 81838 | 0.170 |
Why?
|
Cloning, Molecular | 6 | 2015 | 4163 | 0.160 |
Why?
|
Homeostasis | 1 | 2010 | 3338 | 0.160 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 2 | 2017 | 76 | 0.160 |
Why?
|
NIH 3T3 Cells | 7 | 2019 | 651 | 0.160 |
Why?
|
Dystrophin | 1 | 2000 | 283 | 0.160 |
Why?
|
Genes, erbB-1 | 2 | 2013 | 161 | 0.160 |
Why?
|
Adenosine Triphosphatases | 1 | 2003 | 839 | 0.160 |
Why?
|
Clathrin | 1 | 2020 | 259 | 0.160 |
Why?
|
Receptors, Cell Surface | 8 | 2004 | 2815 | 0.160 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2020 | 299 | 0.150 |
Why?
|
Salmonella typhimurium | 1 | 2001 | 348 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2010 | 1897 | 0.150 |
Why?
|
Pyrazoles | 3 | 2016 | 2031 | 0.150 |
Why?
|
Gene Expression | 6 | 2017 | 7581 | 0.150 |
Why?
|
Foodborne Diseases | 1 | 2018 | 41 | 0.150 |
Why?
|
Serine Endopeptidases | 1 | 2003 | 1027 | 0.150 |
Why?
|
Multiprotein Complexes | 2 | 2022 | 1107 | 0.150 |
Why?
|
Food Analysis | 1 | 2018 | 103 | 0.140 |
Why?
|
Salmonella | 1 | 2018 | 122 | 0.140 |
Why?
|
Cytokinesis | 2 | 2010 | 170 | 0.140 |
Why?
|
Static Electricity | 2 | 2012 | 258 | 0.140 |
Why?
|
Birds | 2 | 2008 | 165 | 0.140 |
Why?
|
Receptors, Mitogen | 2 | 2011 | 61 | 0.140 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 3 | 2014 | 122 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2020 | 465 | 0.140 |
Why?
|
Fluorescence Polarization | 2 | 2021 | 140 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2838 | 0.140 |
Why?
|
Salmonella Infections | 1 | 2018 | 175 | 0.130 |
Why?
|
Acoustics | 1 | 2018 | 237 | 0.130 |
Why?
|
Enzyme Inhibitors | 6 | 2012 | 3722 | 0.130 |
Why?
|
Fluorobenzenes | 1 | 2018 | 179 | 0.130 |
Why?
|
Mutagenesis, Site-Directed | 5 | 2017 | 1677 | 0.130 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.130 |
Why?
|
Molecular Conformation | 3 | 2017 | 539 | 0.130 |
Why?
|
Hedgehog Proteins | 1 | 2021 | 771 | 0.130 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2015 | 46 | 0.130 |
Why?
|
Escherichia coli | 9 | 2015 | 4209 | 0.130 |
Why?
|
Adenocarcinoma | 5 | 2014 | 6361 | 0.130 |
Why?
|
Antigens, CD | 7 | 2004 | 4025 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2003 | 2570 | 0.130 |
Why?
|
Recombinant Proteins | 6 | 2015 | 6492 | 0.130 |
Why?
|
Benzamides | 2 | 2014 | 1376 | 0.130 |
Why?
|
Cell Line | 10 | 2019 | 15545 | 0.130 |
Why?
|
Drug Discovery | 2 | 2021 | 1065 | 0.130 |
Why?
|
Lymphocyte Activation | 2 | 2003 | 5503 | 0.120 |
Why?
|
Cell Membrane | 2 | 2023 | 3635 | 0.120 |
Why?
|
Cell Division | 3 | 2021 | 4467 | 0.120 |
Why?
|
Rabbits | 2 | 2015 | 4730 | 0.120 |
Why?
|
Ligands | 3 | 2019 | 3274 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2024 | 10737 | 0.120 |
Why?
|
Hydrogen Bonding | 5 | 2012 | 290 | 0.120 |
Why?
|
Milk | 1 | 2018 | 436 | 0.120 |
Why?
|
Drug Synergism | 2 | 2016 | 1753 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 2016 | 255 | 0.120 |
Why?
|
Calorimetry | 2 | 2006 | 132 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 5 | 2012 | 3733 | 0.120 |
Why?
|
Amino Acid Substitution | 6 | 2017 | 1742 | 0.120 |
Why?
|
Receptor, IGF Type 1 | 1 | 2017 | 385 | 0.120 |
Why?
|
Conserved Sequence | 3 | 2016 | 1159 | 0.120 |
Why?
|
Quinolines | 3 | 2016 | 769 | 0.110 |
Why?
|
Neurogenesis | 1 | 2021 | 864 | 0.110 |
Why?
|
Crystallization | 2 | 2013 | 518 | 0.110 |
Why?
|
Thermodynamics | 1 | 2015 | 577 | 0.110 |
Why?
|
Biosensing Techniques | 2 | 2018 | 640 | 0.110 |
Why?
|
Cytoplasm | 3 | 2010 | 1498 | 0.110 |
Why?
|
Publications | 1 | 2016 | 195 | 0.110 |
Why?
|
Proteins | 5 | 2016 | 5994 | 0.110 |
Why?
|
Neural Stem Cells | 1 | 2021 | 897 | 0.110 |
Why?
|
Cerebellum | 1 | 2021 | 1519 | 0.110 |
Why?
|
Point Mutation | 6 | 2011 | 1591 | 0.110 |
Why?
|
Cell Adhesion | 3 | 2014 | 3089 | 0.100 |
Why?
|
Autocrine Communication | 1 | 2014 | 167 | 0.100 |
Why?
|
T-Lymphocytes | 4 | 2004 | 10260 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 2 | 2016 | 1195 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
Binding, Competitive | 2 | 2012 | 1140 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3692 | 0.100 |
Why?
|
Repressor Proteins | 1 | 2003 | 2974 | 0.100 |
Why?
|
Receptor, Insulin | 1 | 1996 | 838 | 0.100 |
Why?
|
Structural Homology, Protein | 2 | 2013 | 86 | 0.100 |
Why?
|
Cell Polarity | 2 | 2007 | 636 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2017 | 1160 | 0.100 |
Why?
|
Protein Subunits | 3 | 2022 | 940 | 0.100 |
Why?
|
Resorcinols | 1 | 2012 | 41 | 0.100 |
Why?
|
Models, Chemical | 3 | 2009 | 607 | 0.100 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2013 | 145 | 0.100 |
Why?
|
Cell Survival | 5 | 2019 | 5744 | 0.100 |
Why?
|
Drosophila melanogaster | 2 | 2011 | 1725 | 0.100 |
Why?
|
I-kappa B Kinase | 1 | 2013 | 250 | 0.100 |
Why?
|
Leukemia, B-Cell | 1 | 2012 | 86 | 0.090 |
Why?
|
Aminopyridines | 1 | 2015 | 576 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2014 | 9600 | 0.090 |
Why?
|
rac GTP-Binding Proteins | 1 | 2011 | 163 | 0.090 |
Why?
|
Schiff Bases | 1 | 2010 | 22 | 0.090 |
Why?
|
Cyclic GMP | 1 | 2012 | 394 | 0.090 |
Why?
|
Tropomyosin | 1 | 2011 | 103 | 0.090 |
Why?
|
Mutation, Missense | 5 | 2013 | 2590 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2004 | 620 | 0.090 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2003 | 501 | 0.090 |
Why?
|
Peptide Library | 4 | 2016 | 351 | 0.090 |
Why?
|
Retroviridae | 2 | 2012 | 845 | 0.090 |
Why?
|
Isoxazoles | 1 | 2012 | 233 | 0.090 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2010 | 68 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 862 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1994 | 4342 | 0.080 |
Why?
|
Crystallography | 3 | 2005 | 110 | 0.080 |
Why?
|
Lunate Bone | 1 | 2009 | 38 | 0.080 |
Why?
|
Profilins | 2 | 2007 | 65 | 0.080 |
Why?
|
Triangular Fibrocartilage | 1 | 2009 | 27 | 0.080 |
Why?
|
Cell Physiological Phenomena | 1 | 2010 | 148 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2091 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-fyn | 3 | 2004 | 114 | 0.080 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.080 |
Why?
|
Databases, Genetic | 1 | 2016 | 1755 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2012 | 678 | 0.080 |
Why?
|
Protein Folding | 2 | 2003 | 868 | 0.080 |
Why?
|
Scaphoid Bone | 1 | 2009 | 85 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3605 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2003 | 1524 | 0.080 |
Why?
|
Cell Cycle Proteins | 3 | 2010 | 3436 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.070 |
Why?
|
Gene Deletion | 1 | 2015 | 2667 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 3 | 2004 | 463 | 0.070 |
Why?
|
Cadherins | 2 | 2003 | 900 | 0.070 |
Why?
|
Dexamethasone | 1 | 2015 | 1962 | 0.070 |
Why?
|
Proteomics | 2 | 2023 | 3907 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2009 | 698 | 0.070 |
Why?
|
Cell Movement | 3 | 2012 | 5194 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2012 | 7850 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3787 | 0.070 |
Why?
|
Integrins | 2 | 2020 | 838 | 0.070 |
Why?
|
Affinity Labels | 1 | 2007 | 107 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2025 | 14457 | 0.070 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2010 | 390 | 0.070 |
Why?
|
Wrist Injuries | 1 | 2009 | 215 | 0.070 |
Why?
|
Leukemia | 1 | 2015 | 1521 | 0.070 |
Why?
|
Circular Dichroism | 3 | 2003 | 333 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 109 | 0.070 |
Why?
|
Ligaments, Articular | 1 | 2009 | 306 | 0.070 |
Why?
|
HeLa Cells | 3 | 2020 | 3070 | 0.070 |
Why?
|
Cell Nucleus | 2 | 2016 | 2864 | 0.070 |
Why?
|
Proline | 2 | 2000 | 453 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1559 | 0.060 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 4 | 2001 | 43 | 0.060 |
Why?
|
Lymphoma | 1 | 2015 | 1897 | 0.060 |
Why?
|
Neuropeptides | 1 | 2011 | 950 | 0.060 |
Why?
|
Peptide Fragments | 7 | 2014 | 5125 | 0.060 |
Why?
|
Blood Proteins | 2 | 2005 | 1186 | 0.060 |
Why?
|
Transduction, Genetic | 1 | 2008 | 898 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2001 | 121 | 0.060 |
Why?
|
Myeloproliferative Disorders | 1 | 2012 | 615 | 0.060 |
Why?
|
Hydatidiform Mole, Invasive | 1 | 2005 | 4 | 0.060 |
Why?
|
Glycine | 1 | 2008 | 671 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2048 | 0.060 |
Why?
|
Immunoblotting | 3 | 2013 | 1644 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2003 | 1416 | 0.060 |
Why?
|
Oligopeptides | 1 | 2010 | 1195 | 0.060 |
Why?
|
Isoindoles | 1 | 2024 | 36 | 0.060 |
Why?
|
Repetitive Sequences, Amino Acid | 2 | 2001 | 91 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-cbl | 3 | 2000 | 120 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 4 | 2001 | 225 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5695 | 0.060 |
Why?
|
Codon | 2 | 2017 | 599 | 0.060 |
Why?
|
Transfection | 4 | 2011 | 5739 | 0.060 |
Why?
|
Vaginal Neoplasms | 1 | 2005 | 105 | 0.060 |
Why?
|
Thrombocythemia, Essential | 1 | 2005 | 114 | 0.060 |
Why?
|
Adipocytes, Brown | 1 | 2025 | 160 | 0.060 |
Why?
|
Radius Fractures | 1 | 2009 | 515 | 0.050 |
Why?
|
X-Ray Diffraction | 3 | 2001 | 413 | 0.050 |
Why?
|
Mitochondrial Membranes | 1 | 2025 | 184 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2020 | 4262 | 0.050 |
Why?
|
Purines | 1 | 2007 | 616 | 0.050 |
Why?
|
Polycythemia Vera | 1 | 2005 | 160 | 0.050 |
Why?
|
Chickens | 1 | 2005 | 842 | 0.050 |
Why?
|
Endopeptidase Clp | 1 | 2003 | 42 | 0.050 |
Why?
|
Sequence Analysis, Protein | 1 | 2004 | 261 | 0.050 |
Why?
|
Qc-SNARE Proteins | 1 | 2003 | 21 | 0.050 |
Why?
|
Phosphoserine | 1 | 2003 | 203 | 0.050 |
Why?
|
Qb-SNARE Proteins | 1 | 2003 | 34 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2062 | 0.050 |
Why?
|
Primary Myelofibrosis | 1 | 2005 | 209 | 0.050 |
Why?
|
Aminopeptidases | 1 | 2003 | 114 | 0.050 |
Why?
|
Morphogenesis | 1 | 2007 | 743 | 0.050 |
Why?
|
Gene Knockout Techniques | 2 | 2017 | 800 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2014 | 433 | 0.050 |
Why?
|
Arthroscopy | 1 | 2009 | 969 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6603 | 0.050 |
Why?
|
Endocytosis | 1 | 2007 | 952 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18321 | 0.050 |
Why?
|
Obesity | 1 | 2025 | 13082 | 0.050 |
Why?
|
Transcription Factor 7-Like 1 Protein | 1 | 2001 | 23 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2014 | 3684 | 0.050 |
Why?
|
Asparagine | 1 | 2002 | 120 | 0.050 |
Why?
|
Ciona intestinalis | 1 | 2021 | 10 | 0.050 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2004 | 222 | 0.050 |
Why?
|
Kinetics | 2 | 2008 | 6273 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3679 | 0.050 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 2 | 1999 | 69 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 314 | 0.050 |
Why?
|
Sulfolobus | 1 | 2001 | 4 | 0.050 |
Why?
|
Azepines | 1 | 2003 | 328 | 0.050 |
Why?
|
Dipeptides | 1 | 2003 | 386 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1603 | 0.050 |
Why?
|
TCF Transcription Factors | 1 | 2001 | 137 | 0.050 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2001 | 152 | 0.050 |
Why?
|
Microtubules | 1 | 2007 | 1064 | 0.050 |
Why?
|
EF Hand Motifs | 1 | 2000 | 19 | 0.040 |
Why?
|
Amino Acids | 3 | 2014 | 1711 | 0.040 |
Why?
|
Dystroglycans | 1 | 2000 | 62 | 0.040 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2000 | 74 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2001 | 300 | 0.040 |
Why?
|
Genes, ras | 1 | 2023 | 656 | 0.040 |
Why?
|
Quinazolinones | 1 | 2022 | 219 | 0.040 |
Why?
|
Glioma | 1 | 2015 | 3492 | 0.040 |
Why?
|
Thermogenesis | 1 | 2025 | 495 | 0.040 |
Why?
|
Molecular Chaperones | 1 | 2025 | 760 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21072 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3077 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2003 | 960 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 1994 | 588 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1131 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2003 | 651 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2001 | 372 | 0.040 |
Why?
|
Disulfides | 2 | 2004 | 461 | 0.040 |
Why?
|
Ligases | 1 | 2000 | 330 | 0.040 |
Why?
|
Mice, Nude | 3 | 2012 | 3610 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 2001 | 433 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2889 | 0.040 |
Why?
|
Receptors, Transferrin | 1 | 2020 | 300 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2001 | 492 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2001 | 697 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2547 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3423 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 1999 | 558 | 0.040 |
Why?
|
Phenols | 1 | 2022 | 526 | 0.040 |
Why?
|
Food Microbiology | 1 | 2018 | 73 | 0.040 |
Why?
|
Models, Biological | 4 | 2014 | 9446 | 0.040 |
Why?
|
Protein Engineering | 1 | 2002 | 550 | 0.040 |
Why?
|
Cells, Cultured | 5 | 2013 | 18965 | 0.040 |
Why?
|
Thymus Gland | 1 | 2003 | 1259 | 0.040 |
Why?
|
DNA Primers | 2 | 2012 | 2823 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2021 | 1748 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 271 | 0.030 |
Why?
|
Sequence Deletion | 3 | 2011 | 1494 | 0.030 |
Why?
|
Models, Genetic | 1 | 2007 | 3448 | 0.030 |
Why?
|
Computer Graphics | 2 | 2001 | 345 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 1997 | 198 | 0.030 |
Why?
|
Luciferases | 2 | 2012 | 712 | 0.030 |
Why?
|
GTP Phosphohydrolases | 2 | 2016 | 524 | 0.030 |
Why?
|
Food Contamination | 1 | 2018 | 193 | 0.030 |
Why?
|
beta Catenin | 1 | 2001 | 1047 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2025 | 22339 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11859 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2014 | 3227 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4565 | 0.030 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2001 | 396 | 0.030 |
Why?
|
Peptide Mapping | 1 | 1996 | 259 | 0.030 |
Why?
|
Sound | 1 | 2018 | 257 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2002 | 1742 | 0.030 |
Why?
|
Cell Communication | 1 | 2003 | 1660 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1425 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2015 | 101 | 0.030 |
Why?
|
Leucine | 1 | 2017 | 547 | 0.030 |
Why?
|
Phenylalanine | 1 | 2017 | 367 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
Gallamine Triethiodide | 1 | 1994 | 4 | 0.030 |
Why?
|
Biological Availability | 1 | 2015 | 387 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1739 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6961 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 463 | 0.030 |
Why?
|
Histone Chaperones | 1 | 2014 | 82 | 0.030 |
Why?
|
Protein Interaction Mapping | 2 | 2010 | 620 | 0.030 |
Why?
|
Biocatalysis | 1 | 2014 | 167 | 0.030 |
Why?
|
Lymphotoxin-alpha | 2 | 1994 | 94 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 1994 | 156 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 426 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2025 | 2897 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6057 | 0.030 |
Why?
|
Collagen | 1 | 2001 | 2618 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 210 | 0.030 |
Why?
|
Chemokine CCL5 | 1 | 2014 | 213 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1476 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 837 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 576 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1996 | 901 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 437 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2012 | 11035 | 0.020 |
Why?
|
Molecular Weight | 2 | 1996 | 2161 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2012 | 130 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 572 | 0.020 |
Why?
|
Hormones | 1 | 2016 | 865 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 415 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 1997 | 1459 | 0.020 |
Why?
|
Arginine | 2 | 2010 | 931 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 2390 | 0.020 |
Why?
|
Mitochondria | 1 | 2025 | 3676 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1993 | 341 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2013 | 873 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2012 | 257 | 0.020 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2011 | 187 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 994 | 0.020 |
Why?
|
Isoleucine | 1 | 2010 | 111 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2011 | 246 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7599 | 0.020 |
Why?
|
Base Sequence | 3 | 2013 | 12405 | 0.020 |
Why?
|
Indazoles | 1 | 2012 | 306 | 0.020 |
Why?
|
Genomic Instability | 1 | 2014 | 714 | 0.020 |
Why?
|
Triglycerides | 1 | 1997 | 2441 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3489 | 0.020 |
Why?
|
Apoptosis | 2 | 2016 | 9507 | 0.020 |
Why?
|
Histidine | 1 | 2010 | 301 | 0.020 |
Why?
|
COS Cells | 2 | 2001 | 1135 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2012 | 454 | 0.020 |
Why?
|
Arthrography | 1 | 2009 | 148 | 0.020 |
Why?
|
Male | 12 | 2025 | 363880 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1227 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1989 | 1056 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2004 | 3636 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2001 | 4783 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 2010 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 575 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1664 | 0.020 |
Why?
|
Rupture | 1 | 2009 | 444 | 0.020 |
Why?
|
Mutagenesis | 1 | 2012 | 1227 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14644 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2718 | 0.020 |
Why?
|
Acids | 1 | 2007 | 125 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2921 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9525 | 0.020 |
Why?
|
Capsid | 1 | 1989 | 435 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1623 | 0.020 |
Why?
|
Macrophages | 1 | 2001 | 5775 | 0.020 |
Why?
|
Female | 12 | 2017 | 396174 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9540 | 0.020 |
Why?
|
Bone Plates | 1 | 2009 | 468 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 610 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2007 | 612 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1889 | 0.020 |
Why?
|
Isoenzymes | 1 | 2010 | 1688 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 994 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7474 | 0.020 |
Why?
|
Ubiquitin | 1 | 2010 | 840 | 0.020 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2010 | 723 | 0.020 |
Why?
|
Models, Structural | 1 | 2005 | 338 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1392 | 0.010 |
Why?
|
Indole Alkaloids | 1 | 2004 | 23 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1331 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2464 | 0.010 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2004 | 36 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2626 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2510 | 0.010 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2004 | 87 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 1724 | 0.010 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2004 | 120 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2004 | 124 | 0.010 |
Why?
|
Phospholipids | 1 | 2007 | 777 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3107 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 283 | 0.010 |
Why?
|
Cobalt | 1 | 2003 | 146 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-yes | 1 | 2003 | 17 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
Cyclohexanes | 1 | 2003 | 151 | 0.010 |
Why?
|
Granulocytes | 1 | 2005 | 548 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11906 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2004 | 423 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6215 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 702 | 0.010 |
Why?
|
Fracture Fixation, Internal | 1 | 2009 | 980 | 0.010 |
Why?
|
Sesquiterpenes | 1 | 2003 | 175 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2003 | 367 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1609 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 2005 | 433 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2010 | 1263 | 0.010 |
Why?
|
Chick Embryo | 1 | 2004 | 964 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1980 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2005 | 744 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2825 | 0.010 |
Why?
|
Liver | 1 | 1997 | 7558 | 0.010 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2005 | 287 | 0.010 |
Why?
|
Cell Hypoxia | 1 | 2004 | 656 | 0.010 |
Why?
|
Software | 1 | 2016 | 4463 | 0.010 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 505 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3664 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 1769 | 0.010 |
Why?
|
Dictyostelium | 1 | 2001 | 70 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5879 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6892 | 0.010 |
Why?
|
Stem Cells | 1 | 2014 | 3537 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4161 | 0.010 |
Why?
|
Oncogene Protein v-cbl | 1 | 2000 | 11 | 0.010 |
Why?
|
Adult | 6 | 2017 | 223110 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2001 | 812 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2004 | 496 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 539 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20699 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2005 | 1525 | 0.010 |
Why?
|
Homozygote | 1 | 2005 | 1774 | 0.010 |
Why?
|
Sirolimus | 1 | 2007 | 1541 | 0.010 |
Why?
|
Erythropoietin | 1 | 2004 | 716 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2001 | 738 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2000 | 163 | 0.010 |
Why?
|
Japan | 1 | 2004 | 1414 | 0.010 |
Why?
|
p21-Activated Kinases | 1 | 2000 | 127 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2004 | 2328 | 0.010 |
Why?
|
Middle Aged | 5 | 2017 | 223035 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2017 | 65203 | 0.010 |
Why?
|
Cytokine Receptor gp130 | 1 | 1998 | 66 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3586 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2003 | 1178 | 0.010 |
Why?
|
Janus Kinase 1 | 1 | 1998 | 108 | 0.010 |
Why?
|
Glycosylation | 1 | 2001 | 1099 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2796 | 0.010 |
Why?
|
Methotrexate | 1 | 2005 | 1719 | 0.010 |
Why?
|
Aged | 5 | 2011 | 171170 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 1998 | 227 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2005 | 2039 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2009 | 59497 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1996 | 199 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2266 | 0.010 |
Why?
|
Trypsin | 1 | 1996 | 487 | 0.010 |
Why?
|
Liver Neoplasms | 2 | 2004 | 4354 | 0.010 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1996 | 178 | 0.010 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 1996 | 165 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1996 | 631 | 0.010 |
Why?
|
N-Methylscopolamine | 1 | 1994 | 4 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1996 | 780 | 0.010 |
Why?
|
Scopolamine Derivatives | 1 | 1994 | 23 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 1998 | 872 | 0.010 |
Why?
|
Magnesium | 1 | 1998 | 815 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5019 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4779 | 0.010 |
Why?
|
Methionine | 1 | 1996 | 569 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2046 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 1994 | 135 | 0.010 |
Why?
|
Proteome | 1 | 2003 | 1895 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3499 | 0.010 |
Why?
|
Catalysis | 1 | 1995 | 767 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1996 | 687 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 1995 | 228 | 0.010 |
Why?
|
Biopsy | 1 | 2005 | 6768 | 0.010 |
Why?
|
Perfusion | 1 | 1997 | 1408 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8925 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2532 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 1996 | 723 | 0.010 |
Why?
|
Leukocytes | 1 | 1999 | 2030 | 0.010 |
Why?
|
Lung | 1 | 2009 | 10061 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6101 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 13027 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2729 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1994 | 2476 | 0.010 |
Why?
|
Rats | 1 | 2004 | 23718 | 0.000 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 1996 | 2878 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9378 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 54804 | 0.000 |
Why?
|
Phenotype | 1 | 2001 | 16714 | 0.000 |
Why?
|
Pregnancy | 1 | 2005 | 30228 | 0.000 |
Why?
|
Young Adult | 1 | 2009 | 59858 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11092 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 88808 | 0.000 |
Why?
|
United States | 1 | 2004 | 72918 | 0.000 |
Why?
|